Alzheimer's Disease Education and Referral Center

Search for Clinical Trials

Your Search for state of Oregon Identified 6 Trial(s):

  • 1. AC-1204 for Mild to Moderate Alzheimer's Disease

    Purpose: To evaluate the effects of AC-1204 on cognition, activities of daily living, quality of life, pharmacokinetic measures, and safety in people with mild to moderate Alzheimer's disease.

  • 2. BAN2401 for Early Alzheimer's Disease

    Purpose: To determine the effectiveness of the experimental drug BAN2401 as a possible treatment for people with mild cognitive impairment or mild Alzheimer's disease.

  • 3. Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease

    Purpose: To see if taking lipoic acid and omega-3 fatty acids can slow the Alzheimer's disease process.

  • 4. MK-8931 for Mild to Moderate Alzheimer's Disease

    Purpose: To assess the efficacy and safety of MK-8931 as a possible treatment for Alzheimer's disease.

  • 5. RO4602522 in Patients with Moderate Alzheimer Disease on Donepezil or Rivastigmine Therapy

    Purpose: To evaluate the efficacy and safety of RO4602522 in people with moderate-stage Alzheimer disease who take donepezil or rivastigmine.

  • 6. Systolic Blood Pressure Intervention Trial: Memory and Cognition in Decreased Hypertension (SPRINT-MIND)

    Purpose: To determine whether intensive blood pressure lowering will reduce the incidence of all-cause dementia, reduce the decline of global cognitive function in key specific domains, and show changes in brain structure.

    • Return to AD Clinical Trials Search Results

    Return to AD Clinical Trials Home

    Refine Your Search

    Type in a word or phrase such as drug name,
    disease stage, or trial name
    Input a city and state or zip code
    Enter the distance in number of miles from the location
    (default is 50)
    Age of the participant